Dr. Joseph C. Maroon Joins Lionheart Health's Scientific and Clinical Advisory Board

Dr. Joseph C. Maroon, a renowned neurosurgeon and longevity expert, joins Lionheart Health's advisory board to guide clinical studies on bioelectric therapies targeting brain health and healthspan extension.

Miami Metrowire Staff
Healthcare
Dr. Joseph C. Maroon Joins Lionheart Health's Scientific and Clinical Advisory Board

Lionheart Health, Inc., a leader in bioelectric regenerative medicine and healthspan optimization technologies, announced that Joseph C. Maroon, MD, FACS, has joined its Scientific and Clinical Advisory Board. Dr. Maroon is a board-certified neurosurgeon and Clinical Professor of Neurosurgery at the University of Pittsburgh Medical Center (UPMC), known for his work in brain health, sports neurosurgery, concussion management, and longevity science.

Dr. Maroon's appointment strengthens Lionheart Health's brain health platform, which includes patented bioelectric stimulation technologies such as BodStim™ and Brain Band™. These therapies aim to improve cognition, memory, and mood; support neuroplasticity; reduce systemic and neuroinflammation; and enhance muscle-brain axis signaling. The company is advancing clinical initiatives focused on functional biomarkers of aging, including grip strength, gait speed, cognition, and inflammatory markers.

Howard Leonhardt, Founder and Executive Chairman of Lionheart Health, stated, "Dr. Maroon's decades of leadership in neurosurgery and preventive brain health bring exceptional scientific credibility and clinical insight to Lionheart Health. His work bridging neuroscience, inflammation control, and longevity science aligns perfectly with our mission to increase healthspan."

Dr. Maroon commented, "Optimizing brain health is central to extending meaningful healthspan. I look forward to supporting Lionheart Health's efforts to scientifically validate innovative bioelectric therapies that aim to improve neurological resilience, reduce inflammation, and enhance overall vitality."

Lionheart Health's intellectual property portfolio includes patents targeting regenerative and neuroprotective signaling pathways such as Klotho, BDNF, GDF10, SDF-1, PDGF, and eNOS. The company is preparing to enroll in a clinical trial combining BodStim™ and Brain Band™ for brain health, following successful pilot studies. Lionheart Health was recognized as 2025 Micro Stimulator Developer of the Year by Medtech Outlook Magazine and recently won the Abbvie Allergan ULP Innovation Award.

Dr. Maroon brings more than four decades of experience in academic neurosurgery and has served as Team Neurosurgeon for the Pittsburgh Steelers. He has published over 300 peer-reviewed articles and authored best-selling books including Square One, which emphasizes foundational strategies for brain and body health. His expertise will guide Lionheart Health's brain health clinical study design, neurocognitive endpoint validation, and integration of lifestyle and bioelectric strategies for healthspan extension.

For more information, visit Lionheart Health's website.

Blockchain Registration

QR Code for Blockchain Registration